# Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection

> **NCT02589847** · PHASE2 · COMPLETED · sponsor: **Rebiotix Inc.** · enrollment: 272 (actual)

## Conditions studied

- Clostridium Difficile Infection

## Interventions

- **BIOLOGICAL:** RBX2660
- **DRUG:** Standard of Care Antibiotics

## Key facts

- **NCT ID:** NCT02589847
- **Lead sponsor:** Rebiotix Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2017-06
- **Final completion:** 2019-03
- **Target enrollment:** 272 (ACTUAL)
- **Last updated:** 2021-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02589847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02589847, "Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02589847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*